v3.26.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Net income (loss) $ 13,132 $ (4,157)
Adjustments to reconcile net income (loss) to net cash from operating activities:    
Stock-based compensation 2,986 3,296
Depreciation and amortization 2,517 2,018
Inventory step-up 1,000 2,349
Excess and obsolete inventory reserve 581 110
Debt discount amortization and non-cash interest expenses 278 342
Non-cash lease expense 45 30
Changes in operating assets and liabilities:    
Accounts receivable (13,129) (9,092)
Inventories 4,725 (11,019)
Prepaid expenses and other assets 739 672
Accounts payable 3,429 7,970
Accrued Medicaid rebates 1,652 9,359
Accrued liabilities 704 (1,201)
Other non-current assets and liabilities (3,999) 9,372
Net cash from operating activities 14,660 10,049
Cash flows used in investing activities    
Purchases of product license rights (15,000) 0
Purchases of property and equipment (70) 0
Net cash used in investing activities (15,070) 0
Cash flows from financing activities    
Proceeds from stock option exercises 4,043 394
Proceeds from shares issued under the ESPP 270 0
Repayment of long-term debt (3,000) 0
Net cash from financing activities 1,313 394
Change in cash and cash equivalents 903 10,443
Cash and cash equivalents at beginning of period 25,942 14,936
Cash and cash equivalents at end of period 26,845 25,379
Supplemental disclosures of cash flow information    
Cash paid for interest 1,697 852
Cash paid for income taxes $ 85 $ 89